The effect of pentadecapeptide BPC 157, H2-blockers, omeprazole and sucralfate on new vessels and new granulation tissue formation

Journal of Physiology Paris

Volumn 93, Issue 6, 1999, Pages 479-485

  Sikiric, Predrag ^a   Šeparovic, Jadranka ^a   Anic, Tomislav ^a   Buljat, Gojko ^a   Mikus, Darko ^a   Seiwerth, Sven ^a   Grabarevic, Zeljko ^a   Stancic Rokotov, Dinko ^a   Pigac, Biserka ^a   Hanzevacki, Miroslav ^a   Marovic, Anton ^a   Rucman, Rudolf ^a   Petek, Marijan ^a   Zoricic, Ivan ^a   Ziger, Tomislav ^a   Aralica, Gorana ^a   Konjevoda, Pasko ^a   Prkacin, Ingrid ^a   Gjurašin, Miroslav ^a   Miklic, Pavle ^a   Artukovic, Branka ^a   Tišljar, Marina ^a   Bratulic, Mirna ^a   Mise, Stjepan ^a   Rotkvic, Ivo ^a   more..

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Angiogenesis; Granulation; H2 blockers; Omeprazole; Pentadecapeptide BPC 157; Promotion; Sucralfate

Indexed keywords

ANTIULCER AGENT; CIMETIDINE; FAMOTIDINE; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALANYLGLYCYLLEUCYLVALINE; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PEPTORAN; RANITIDINE; SUCRALFATE; ULFAMID; ULTOP; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GRANULATION TISSUE; MALE; NONHUMAN; RAT; ULCER;

EID: 0033380855     PISSN: 09284257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4257(99)00123-0     Document Type: Conference Paper

References (40)

1. Bosnjak Z.J., Graf B.M., Sikiric P., Stowe D.F. Protective effects of newly isolated gastric peptide following hypoxic and reoxygenation injury in the isolated guinea pig heart. FASEB J. 8:1994;A129.
2. Clissold S.P., Campoli-Richards D.M. Omeprazole. An updated review. Drugs. 32:1986;15-47.
3. Folkman J., Szabo S., Shing Y. Sucralfate affinity for fibroblast growth factor. J. Cell Biol. 111:1990;223A.
4. Grabarevic Z., Tisljar M., Artukovic B., Bratulic M., Dzaja P., Seiwerth S., Sikiric P., Peric J., Geres D., Kos J. The influence of BPC 157 on nitric-oxyde agonists and antagonist induced lesions in broiler chicks. J. Physiol. 91:1997;139-150.
5. Guglietta A. Possible clinical use of peptide growth factors in the GI tract: perspectives and obstacles. Exp. Clin. Gastroenterol. 3:1992;1-6.
6. Hawkey C.J., Hull M.A. Angiogenesis, basic fibroblast growth factor and human gastric ulcer healing. Digestion. 55 (S2):1994;12.
7. Jelovac N., Sikiric P., Rucman R., Petek M., Perovic D., Konjevoda P., Marovic A., Seiwerth S., Grabarevic Z., Sumajstorcic J., Dodig G. A novel pentadecapeptide BPC 157 blocks the stereotype produced acutely by amphetamine and the development of haloperidol-induced supersensitivity to amphetamine. Biol. Psych. 43:1998;511-519.
8. Kalogjera L., Ries N., Baudoin T., Ferencic Z., Protic R., Pegan B. Dose dependent protective effect of BPC 157 in capsaicin induced rhinitis in rats. Eur. Arch. Otorhynolaringol. 254:1997;S9-S11.
9. LeGrand E.K., Burke J.F., Costa D.E., Kiorpes T.C. Dose responsive effects of PDGF-BB, PDGF-AA, EGF, and bFGF on granulation tissue in a guinea pig partial thickness skin excision model. Growth Factors. 8:1993;307-314.
10. Mustoe T.A., Pierce G., Thomason A., Gramates P., Sporn M.B., Deuel T.F. Accelerated healing of incisional wounds in rats induced by transforming growth factor-β Science. 237:1987;1333-1336.
11. Paré W., Kluczynski J.M. The effect of new gastric juice peptide BPC on classic stress triad in stress procedure. Exp. Clin. Gastroenterol. 2:1994;234-236.
12. Robert A. Cytoptotection by prostaglandins. Gastroenterology. 77:1979;761-767.
13. Robert A., Lancaster C., Olafsson A.S., Gilbertson-Beadling S., Zhang W. Gastric adaptation to the ulcerogenic effect of aspirin. Exp. Clin. Gastroenterol. 1:1991;73-81.
14. Sandor Z., Vincze A., Szabo S. The protective effect of a recently isolated gastric peptide in acute and chronic gastroduodenal injury. FASEB J. 10:1996;171.
15. Seiwerth S., Sikiric P., Grabarevic Z., Zoricic I., Hanzevacki M., Ljubanovic D., Coric V., Konjevoda P., Petek M., Rucman R., Turkovic B., Perovic D., Mikus D., Jadrijevic S., Medvidovic M., Tadic T., Romac B., Kos J., Peric J., Kolega Z. BPC 157 effect on healing. J. Physiol. (Paris). 91:1997;173-178.
16. Sikiric P., Banic M., Brkic T., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Anic B., Rotkvic I., Duvnjak M., Veljaca M., Simicevic V. Effect of a novel pentadecapeptide BPC 157 and methylprednisolone in a murine model of inflammatory bowel disease. Gastroenterology. 104:1993;782.
17. Sikiric P., Gyires K., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Rotkvic I., Turkovic B., Udovicic I., Jagic V., Mildner B., Duvnjak M., Danilovic Z. The effect of pentadecapeptide BPC 157 on inflammatory, non-inflammatory, direct and indirect pain and capsaicin neurotoxicity. Inflammopharmacology. 2:1993;121-127.
18. Sikiric P., Petek M., Rucman R., Seiwerth S., Grabarevic Z., Rotkvic I., Turkovic B., Jagic V., Mildner B., Duvnjak M., Lang N. A new gastric juice peptide BPC - an overview of stomach/stress/organoprotection hypothesis and BPC beneficial effects. J. Physiol. (Paris). 87:1993;313-327.
19. 4 application. A comparative study with dopamine agonists and somatostatin. Life Sci. 53:1993;PL291-PL296.
20. Sikiric P., Seiwerth S., Grabarevic Z., Petek M., Rucman R., Turkovic B., Rotkvic I., Jagic V., Duvnjak M., Mise S., Djacic S., Separovic J., Veljaca M., Sallmani A., Banic M., Brkic T. The beneficial effect of BPC 157, a 15 aminoacid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promotors and gut peptides. Life Sci. 54:1994;PL63-PL68.
21. Sikiric P., Rotkvic I., Mise S., Seiwerth S., Grabarevic Z., Petek M., Rucman R., Zjacic-Rotkvic V., Duvnjak M., Jagic V., Suchanek E., Marovic A., Banic M., Brkic T., Hanzevacki M., Separovic J., Djacic S., Simicevic V. Dopamine agents efficacy in peptic ulcer healing and relapse prevention - a further indication for importance of stomach dopamine in the stress organoprotection concept. Szabo S, Taché Y, Glavin G. Neuroendocrinology of Gastrointestinal Ulceration: Hans Selye Symposia on Neuroendocrinology and Stress, vol. 2. 1995;221-230 Plenum Publishing Corporation, New York.
22. Sikiric P., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Jagic V., Turkovic B., Rotkvic I., Mise S., Zoricic I., Gjurasin M., Konjevoda P., Separovic J., Ljubanovic D., Artukovic B., Bratulic M., Tisljar M., Jurina L.J., Buljat G., Miklic P., Marovic A. The beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin and capsaicin neurotoxicity. Dig. Dis. Sci. 41:1996;1604-1614.
23. Sikiric P., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Jagic V., Turkovic B., Rotkvic I., Mise S., Zoricic I., Jurina J., Konjevoda P., Hanzevacki M., Ljubanovic D., Separovic J., Gjurasin M., Bratulic M., Artukovic B., Jelovac N., Buljat G. Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in rats. Dig. Dis. Sci. 41:1996;1518-1526.
24. Sikiric P., Mazul B., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Jagic V., Turkovic B., Rotkvic I., Mise S., Zoricic I., Jurina L., Konjevoda P., Hanzevacki M., Gjurasin M., Separovic J., Ljubanovic D., Artukovic M., Bratulic M., Tisljar M., Miklic P., Sumajstorcic J. Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress. Dig. Dis. Sci. 42:1997;661-671.
25. Sikiric P., Mikus D., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Jagic V., Turkovic B., Rotkvic I., Mise S., Zoricic I., Peric J., Konjevoda P., Perovic D., Jurina L., Hanzevacki M., Separovic J., Gjurasin M., Jadrijevic S., Jelovac N., Miklic P., Buljat G., Marovic A. Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine and atropine effect in cysteamine lesions in totally gastrectomized rats. A model study for cytoprotective studies. Dig. Dis. Sci. 42:1997;1029-1037.
26. G-nitro-L-arginine methylester and L-arginine effect on stomach mucosal integrity and blood pressure. Eur. J. Pharmacol. 332:1997;23-32.
27. Sikiric P., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Jagic V., Turkovic B., Rotkvic I., Mise S., Zoricic I., Perovic D., Simicevic V., Hanzevacki M., Ljubanovic D., Artukovic M., Bratulic M., Tisljar M., Rekic B., Gjurasin M., Miklic P., Buljat G. Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agents-induced gastrointestinal lesions and adjuvant arthritis in rats. J. Physiol. (Paris). 91:1997;113-122.
28. Szabo S. Dopamine disorder in duodenal ulceration. Lancet. 2:1979;880-882.
29. Szabo S., Trier J.S., Brown A., Schnoor J. Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat. Gastroenterology. 88:1985;228-236.
30. Szabo S., Vattay P., Scarbrough E., Folkman J. Role of vascular factors, including angiogenesis, in the mechanisms of action of sucralfate. Am. J. M. 91 (2A):1991;158S-160S.
31. Szabo S., Kusstascher S., Sandor Z., Sakoulas G. Growth factors, especially bFGF and PDGR, as novel antiulcer agents. Digestion. 55 (S2):1994;41-42.
32. Tarnawski A., Stachura J., Krause W.J., Douglass T.G., Gergely H. Quality of gastric ulcer healing: a new, emerging concept. J. Clin. Gastroenterol. 13 (Suppl. 1):1991;S42-S47.
33. Thompson J., Greeley Jr G.H., Rayford P.L., Twonsed Jr C.M. Gastrointestinal endocrinology. 1987;McGraw-Hill Book Company, New York.
34. Tsukamoto Y., Tsuchida T., Goto H., Hase S., Arisawa T., Niwa Y. Short report: effect of sucralfate on angiogenesis in granulation tissue of acetic acid-induced gastric ulcers in rats. Alim. Pharmacol. Ther. 7 (5):1993;81-84.
35. Utley R.J., Salim A.S.M., Carter D.C. Effect of cimetidine and omeprazole on aspirin- and taurocholate-induced gastric mucosal damage in the rat. Gut. 26:1985;770-775.
36. Veljaca M., Lech C.A., Pllana R., Sanchez B., Chan K., Guglietta A. BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J. Pharmacol. Exp. Ther. 272:1994;417-422.
37. Veljaca M., Pllana R., Lesch C.A., Sanchez B., Chan K., Guglietta A. Protective effect of BPC 157 on a rat model of colitis. Gastroenterology. 106:1994;789.
38. Veljaca M., Chan K., Guglietta A. Digestion of h-EGF, h-TGF alfa, and BPC 15 in human gastric juice. Gastroenterology. 108:1995;761.
39. Veljaca M., Lesch C.A., Sanchez B., Low J., Guglietta A. Protection of BPC-15 on TNBS-induced colitis in rats: possible mechanisms of action. Gastroenterology. 108:1995;936.
40. Whittle B.J.R., Boughton-Smith N.K., Moncada S. Biosynthesis and role of the endothelium-derived vasodilator, nitric oxide in gastric mucosa. Ann. N. Y. Acad. Sci. 664:1992;126-139.